Cargando…
Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression
Chronic Lymphocytic Leukemia (CLL) is a heterogeneous B cell neoplasm ranging from indolent to rapidly progressive disease. Leukemic cell subsets with regulatory properties evade immune clearance; however, the contribution of such subsets during CLL progression is not completely elucidated. Here, we...
Autores principales: | Mékinian, Arsène, Quinquenel, Anne, Belkacem, Koceïla Ait, Kanoun, Feriel, Dondi, Elisabetta, Franck, Emilie, Boubaya, Marouane, Mhibik, Maïssa, Baran-Marszak, Fanny, Letestu, Rémi, Ajchenbaum-Cymbalista, Florence, Lévy, Vincent, Varin-Blank, Nadine, Le Roy, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353928/ https://www.ncbi.nlm.nih.gov/pubmed/36973425 http://dx.doi.org/10.1038/s41417-023-00602-5 |
Ejemplares similares
-
Targeting early B-cell receptor signaling induces apoptosis in leukemic mantle cell lymphoma
por: Boukhiar, Mohand-Akli, et al.
Publicado: (2013) -
Induction of endoplasmic reticulum calcium pump expression during early leukemic B cell differentiation
por: Aït Ghezali, Lamia, et al.
Publicado: (2017) -
Impact of Low-Burden TP53 Mutations in the Management of CLL
por: Lazarian, Gregory, et al.
Publicado: (2022) -
Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia
por: Saint-Georges, Stéphane, et al.
Publicado: (2016) -
A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
por: Souissi, Inès, et al.
Publicado: (2012)